Brain, Vol. 119, No. 3, 775-787, 1996
© 1996 Guarantors of Brain
research-article |
Selective loss of myelin-associated glycoprotein from myelin correlates with anti-MAG antibody titre in demyelinating paraproteinaemic polyneuropathy
1Departments of Research and Clinical Neurology, University Hospital Basel Switzerland 2Departments of Clinical Neurology, University Hospital Basel Switzerland 3Division of Neurology Research, Children's Hospital Philadelphia, USA 4Service d'Anatomie Pathologique, Hopital Pellegrin Bordeaux, France
Correspondence to:
Correspondence to: A. J. Steck, Neurology Clinic, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland
The IgM monoclonal autoantibodies of patients with demyelinating paraproteinaemic polyneuropathy recognize a carbohydrate structure present on both myelin-associated glycoprotein (MAG) and protein zero (Po). These autoantibodies are sufficient to cause the disease but the mechanism of demyelination remains unclear. We have analysed nerve biopsies from eight patients with polyneuropathy and anti-MAG antibodies by quantitative immunohistochemistry and find a concordant pattern of reduced expression of myelin markers with the loss of myelinated fibres. We report here novel features of this disease, in particular a selective lack of detectable MAG in a large proportion of myelinated fibres containing Po, myelin basic protein (MBP) and periaxin. There is also an inverse correlation of the distribution of MAG in peripheral never myelin with the serum anti-MAG antibody titres but no correlation of these titres with the loss of myelinated fibres. Double immunofluorescence staining of paraproteinaemic polyneuropathy (PPN) nerves shows anti-MAG IgM deposited on the periphery of myelinated fibres associated with or lacking MAG staining. These data suggest that the binding of anti-MAG antibodies to MAG and/or other myelin component(s) results in MAG downregulation and may have an essential role in the molecular mechanisms leading to demyelination and partial regeneration in this disease.
myelin-associated glycoprotein; anti-MAG autoantibodies; paraproteinaemic polyneuropathy; enzyme immunohistochemistry; quantitative image analysis
Received November 10, 1995. Revised January 24, 1996. Accepted February 6, 1996.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Eurelings, K.G.M. Moons, N.C. Notermans, L.D. Sasker, A.E.J. De Jager, A.R. Wintzen, J.H.J. Wokke, and L.H. Van den Berg Neuropathy and IgM M-proteins: Prognostic value of antibodies to MAG, SGPG, and sulfatide Neurology, January 23, 2001; 56(2): 228 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Fields Cell Adhesion Molecules: Implications for Neurological Disease Neuroscientist, January 1, 1998; 4(1): 4 - 8. [PDF] |
||||

